Direct p53 Transcriptional Repression: In Vivo Analysis of CCAAT-Containing G₂/M Promoters

REFERENCES

• Appella, E., and C. W. Anderson. 2001. Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem. 268:2764–2772.
   PubMedGoogle Scholar
• Ard, P. G., C. Chatterjee, S. Kunjibettu, L. R. Adside, L. E. Gralinski, and S. B. McMahon. 2002. Transcriptional regulation of the mdm2 oncogene by p53 requires TRRAP acetyltransferase complexes. Mol. Cell. Biol. 22:5650–5661.
   PubMed Web of Science ®Google Scholar
• Barlev, N. A., L. Liu, N. H. Chehab, K. Mansfield, K. G. Harris, T. D. Halazonetis, and S. L. Berger. 2001. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol. Cell 8:1243–1254.
   PubMed Web of Science ®Google Scholar
• Bolognese, F., M. Wasner, C. Lange-zu Dohna, A. Gurtner, A. Ronchi, H. Muller, I. Manni, J. Mossner, G. Piaggio, R. Mantovani, and K. Engeland. 1999. The cyclin B2 promoter depends on NF-Y, a trimer whose CCAAT-binding activity is cell-cycle regulated. Oncogene 18:1845–1853.
   PubMed Web of Science ®Google Scholar
• Brand, M., J. G. Moggs, M. Oulad-Abdelghani, F. Lejeune, F. J. Dilworth, J. Stevenin, G. Almouzni, and L. Tora. 2001. UV-damaged DNA-binding protein in the TFTC complex links DNA damage recognition to nucleosome acetylation. EMBO J. 20:3187–3196.
   PubMed Web of Science ®Google Scholar
• Caretti, G., V. Salsi, C. Vecchi, C. Imbriano, and R. Mantovani. 2003. Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters. J. Biol. Chem. 278:30435–30440.
   PubMed Web of Science ®Google Scholar
• Chae, H. D., J. Yun, Y. J. Bang, and D. Y. Shin. 2004. Cdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycle-regulatory genes and cell cycle G1/S and G2/M transitions. Oncogene 23:4084–4088.
   PubMed Web of Science ®Google Scholar
• Currie, R. A. 1998. Biochemical characterization of the NF-Y transcription factor complex during B lymphocyte development. J. Biol. Chem. 273:1430–1434.
   PubMedGoogle Scholar
• Elkon, R., C. Linhart, R. Sharan, R. Shamir, and Y. Shiloh. 2003. Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. Genome Res. 13:773–780.
   PubMed Web of Science ®Google Scholar
• Espinosa, J. M., and B. Emerson. 2001. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol. Cell 8:57–69.
   PubMed Web of Science ®Google Scholar
• Farina, A., I. Manni, G. Fontemaggi, M. Tiainen, C. Cenciarelli, M. Bellorini, R. Mantovani, A. Sacchi, and G. Piaggio. 1999. Down-regulation of cyclin B1 gene transcription in terminally differentiated skeletal muscle cells is associated with loss of functional CCAAT-binding NF-Y complex. Oncogene 18:2818–2827.
   PubMedGoogle Scholar
• Flatt, P. M., L. J. Tang, C. D. Scatena, S. T. Szak, and J. A. Pietenpol. 2000. p53 regulation of G2 checkpoint is retinoblastoma protein dependent. Mol. Cell. Biol. 20:4210–4223.
   PubMed Web of Science ®Google Scholar
• Frontini, M., C. Imbriano, A. diSilvio, B. Bell, A. Bogni, C. Romier, D. Moras, L. Tora, I. Davidson, and R. Mantovani. 2002. NF-Y recruitment of TFIID, multiple interactions with histone fold TAF(II)s. J. Biol. Chem. 277:5841–5848.
   PubMedGoogle Scholar
• Gowri, P. M., J. H. Yu, A. Shaufl, M. A. Sperling, and R. K. Menon. 2003. Recruitment of a repressosome complex at the growth hormone receptor promoter and its potential role in diabetic nephropathy. Mol. Cell. Biol. 23:815–825.
   PubMedGoogle Scholar
• Gu, W., and R. G. Roeder. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90:605–606.
   Google Scholar
• Hoffman, W. H., S. Biade, J. T. Zilfou, J. Chen, and M. Murphy. 2002. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J. Biol. Chem. 277:3248–3257.
   Google Scholar
• Innocente, S. A., J. L. Abrahamson, J. P. Cogswell, and J. M. Lee. 1999. p53 regulates a G2 checkpoint through cyclin B1. Proc. Natl. Acad. Sci. USA 96:2148–2152.
   Google Scholar
• Ito, A., C. H. Lai, X. Zhao, S. Saito, M. H. Hamilton, E. Appella, and T. P. Yao. 2001. p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J. 20:1331–1340.
   PubMed Web of Science ®Google Scholar
• Izumi, H., C. Molander, L. Z. Penn, A. Ishisaki, K. Kohno, and K. Funa. 2001. Mechanism for the transcriptional repression by c-Myc on PDGF beta-receptor. J. Cell Sci. 114:1533–1544.
   PubMed Web of Science ®Google Scholar
• Jin, S., and K. W. Scotto. 1998. Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol. Cell. Biol. 18:4377–4384.
   PubMed Web of Science ®Google Scholar
• Jung, M. S., J. Yun, H. D. Chae, J. M. Kim, S. C. Kim, T. S. Choi, and D. Y. Shin. 2001. p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor. Oncogene 20:5818–5825.
   PubMedGoogle Scholar
• Kaeser, M. D., and R. D. Iggo. 2002. Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc. Natl. Acad. Sci. USA 99:95–100.
   PubMed Web of Science ®Google Scholar
• Kao, G. D., W. G. McKenna, M. G. Guenther, R. J. Muschel, M. A. Lazar, and T. J. Yen. 2003. Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response. J. Cell Biol. 160:1017–1027.
   PubMed Web of Science ®Google Scholar
• Kim, I. S., S. Sinha, B. de Crombrugghe, and S. N. Maity. 1996. Determination of functional domains in the C subunit of the CCAAT-binding factor (CBF) necessary for formation of a CBF-DNA complex: CBF-B interacts simultaneously with both the CBF-A and CBF-C subunits to form a heterotrimeric CBF molecule. Mol. Cell. Biol. 16:4003–4013.
   PubMed Web of Science ®Google Scholar
• Kokontis, J. M., A. J. Wagner, M. O'Leary, S. Liao, and N. Hay. 2001. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function. Oncogene 20:660–668.
   Google Scholar
• Koumenis, C., R. Alarcon, E. Hammond, P. Sutphin, W. Hoffman, M. Murphy, J. Derr, Y. Taya, S. W. Lowe, M. Kastan, and A. Giaccia. 2001. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol. Cell. Biol. 21:1297–1310.
   PubMed Web of Science ®Google Scholar
• Krause, K., M. Wasner, W. Reinhard, U. Haugwitz, C. L. Dohna, J. Mossner, and K. Engeland. 2000. The tumour suppressor protein p53 can repress transcription of cyclin B. Nucleic Acids Res. 28:4410–4418.
   PubMed Web of Science ®Google Scholar
• Juan, L. J., W. J. Shia, M. H. Chen, W. M. Yang, E. Seto, Y. S. Lin, and C. W. Wu. 2000. Histone deacetylases specifically down-regulate p53-dependent gene activation. J. Biol. Chem. 275:20436–20443.
   PubMed Web of Science ®Google Scholar
• Liu, L., D. M. Scolnick, R. C. Trievel, H. B. Zhang, R. Marmorstein, T. D. Halazonetis, and S. L. Berger. 1999. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol. Cell. Biol. 19:1202–1209.
   PubMed Web of Science ®Google Scholar
• Lohr, K., C. Moritz, A. Contente, and M. Dobbelstein. 2003. p21/CDKN1A mediates negative regulation of transcription by p53. J. Biol. Chem. 278:32507–32516.
   PubMed Web of Science ®Google Scholar
• Maity, A., W. G. McKenna, and R. J. Muschel. 1995. Evidence for post-transcriptional regulation of cyclin B1 mRNA in the cell cycle and following irradiation in HeLa cells. EMBO J. 14:603–609.
   PubMed Web of Science ®Google Scholar
• Manni, I., G. Mazzero, A. Gurtner, R. Mantovani, U. Haugwitz, K. Krause, K. Engeland, A. Sacchi, S. Soddu, and G. Piaggio. 2001. NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and Cdc25C promoters upon induced G2 arrest. J. Biol. Chem. 276:5570–5576.
   PubMedGoogle Scholar
• Mantovani, R. 1999. The molecular biology of the CCAAT-binding factor NF-Y. Gene 239:15–27.
   PubMed Web of Science ®Google Scholar
• Martinez, E., V. B. Palhan, A. Tjernberg, E. S. Lymar, A. M. Gamper, T. K. Kundu, B. T. Chait, and R. G. Roeder. 2001. Human STAGA complex is a chromatin-acetylating transcription coactivator that interacts with pre-mRNA splicing and DNA damage-binding factors in vivo. Mol. Cell. Biol. 20:6782–6795.
   Google Scholar
• Matsui, T., Y. Katsuno, T. Inoue, F. Fujita, T. Joh, H. Niida, H. Murakami, M. Itoh, and M. Nakanishi. 2004. Negative regulation of Chk2 expression by p53 is dependent on the CCAAT-binding transcription factor NF-Y. J. Biol. Chem. 279:25093–25100.
   PubMedGoogle Scholar
• Mirza, A., M. McGuirk, T. N. Hockenberry, Q. Wu, H. Ashar, S. Black, S. F. Wen, L. Wang, P. Kirschmeier, W. R. Bishop, L. L. Nielsen, C. B. Pickett, and S. Liu. 2002. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 21:2613–2622.
   PubMed Web of Science ®Google Scholar
• Murphy, M., J. Ahn, K. K. Walker, W. H. Hoffman, R. M. Evans, A. J. Levine, and D. L. George. 1999. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev. 13:2490–2501.
   PubMed Web of Science ®Google Scholar
• Park, S. H., S. R. Lee, B. C. Kim, E. A. Cho, S. P. Patel, H. B. Kang, E. A. Sausville, O. Nakanishi, J. B. Trepel, B. I. Lee, and S. J. Kim. 2002. Transcriptional regulation of the transforming growth factor beta type II receptor gene by histone acetyltransferase and deacetylase is mediated by NF-Y in human breast cancer cells. J. Biol. Chem. 277:5168–5174.
   PubMed Web of Science ®Google Scholar
• Passalaris, T. M., J. A. Benanti, L. Gewin, T. Kiyono, and D. A. Galloway. 1999. The G2 checkpoint is maintained by redundant pathways. Mol. Cell. Biol. 19:5872–5881.
   PubMed Web of Science ®Google Scholar
• Peng, Y., and N. Jahroudi. 2003. The NFY transcription factor inhibits von Willebrand factor promoter activation in non-endothelial cells through recruitment of histone deacetylases. J. Biol. Chem. 278:8385–8394.
   PubMedGoogle Scholar
• Prives, C., and J. L. Manley. 2002. Why is p53 acetylated. Cell 107:815–818.
   Google Scholar
• Ren, B., H. Cam, Y. Takahashi, T. Volkert, J. Terragni, and R. A. Young., and B. D. Dynlacht. 2002. E2F integrates cell cycle progression with DNA repair, replication and G(2)/M checkpoints. Genes Dev. 16:245–256.
   PubMed Web of Science ®Google Scholar
• Romier, C., F. Cocchiarella, R. Mantovani, and D. Moras. 2003. The NF-YB/NF-YC structure gives insight into DNA binding and transcription regulation by CCAAT factor NF-Y. J. Biol. Chem. 278:1336–1345.
   PubMedGoogle Scholar
• Sakaguchi, K., J. E. Herrera, S. Saito, T. Miki, M. Bustin, A. Vassilev, C. W. Anderson, and E. Appella. 1998. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12:2831–2841.
   PubMed Web of Science ®Google Scholar
• Salsi, S., G. Caretti, M. Wasner, W. Reinhard, U. Haugwitz, K. Engeland, and R. Mantovani. 2003. Interactions between p300 and multiple NF-Y trimers govern cyclin B2 promoter function. J. Biol. Chem. 278:6642–6650.
   PubMed Web of Science ®Google Scholar
• Schiltz, R. L., and Y. Nakatani. 2000. The PCAF acetylase complex as a potential tumor suppressor. Biochim. Biophys. Acta 1480:M37–M53.
   Google Scholar
• Sciortino, S., A. Gurtner, I. Manni, G. Fontemaggi, A. Dey, A. Sacchi, K. Ozato, and G. Piaggio. 2001. The cyclin B1 gene is actively transcribed during mitosis in HeLa cells. EMBO Rep. 2:1018–1023.
   PubMedGoogle Scholar
• Szak, S. T., D. Mays, and J. A. Pietenpol. 2001. Kinetics of p53 binding to promoter sites in vivo. Mol. Cell. Biol. 21:3375–3386.
   PubMed Web of Science ®Google Scholar
• Takahashi, Y., J. B. Rayman, and B. D. Dynlacht. 2000. Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev. 14:804–816.
   PubMed Web of Science ®Google Scholar
• Taylor, W. R., and G. R. Stark. 2001. Regulation of the G2/M transition by p53. Oncogene 20:1803–1815.
   PubMed Web of Science ®Google Scholar
• Taylor, W. R., S. E. DePrimo, A. Agarwal, M. L. Agarwal, A. H. Schonthal, K. S. Katula, and G. R. Stark. 1999. Mechanisms of G2 arrest in response to overexpression of p53. Mol. Biol. Cell 19:3607–3622.
   Google Scholar
• Taylor, W. R., A. H. Schonthal, J. Galante, and G. R. Stark. 2001. p130/E2F4 binds to and represses the Cdc2 promoter in response to p53. J. Biol. Chem. 276:1998–2006.
   PubMed Web of Science ®Google Scholar
• Wang, T., T. Kobayashi, R. Takimoto, A. E. Denes, E. L. Snyder, W. S. el-Deiry, and R. K. Brachmann. 2001. hADA3 is required for p53 activity. EMBO J. 20:6404–6413.
   PubMed Web of Science ®Google Scholar
• Wasner, M., K. Tschop, K. Spiesbach, U. Haugwitz, C. Johne, J. Mossner, R. Mantovani, and K. Engeland. 2003. Cyclin B1 transcription is enhanced by the p300 coactivator and regulated during the cell cycle by a CHR-dependent repression mechanism. FEBS Lett. 536:66–70.
   PubMed Web of Science ®Google Scholar
• Weinmann, A. S., P. S. Yan, M. J. Oberley, T. H. Huang, and P. J. Farnham. 2002. Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev. 16:235–244.
   PubMed Web of Science ®Google Scholar
• Wells, J., K. E. Boyd, C. J. Fry, S. M. Bartley, and P. J. Farnham. 2000. Target gene specificity of E2F and pocket protein family members in living cells. Mol. Cell. Biol. 20:5797–5807.
   PubMed Web of Science ®Google Scholar
• Yamagoe, S., T. Kanno, Y. Kanno, S. Sasaki, R. M. Siegel, M. J. Lenardo, G. Humphrey, Y. Wang, Y. Nakatani, B. H. Howard, and K. Ozato. 2003. Interaction of histone acetylases and deacetylases in vivo. Mol. Cell. Biol. 23:1025–1033.
   PubMed Web of Science ®Google Scholar
• Yoon, H. S., and V. W. Yang. 2004. Requirement of Kruppel-like factor 4 in preventing entry into mitosis following DNA damage. J. Biol. Chem. 279:5035–5041.
   PubMed Web of Science ®Google Scholar
• Yun, J., H. D. Chae, H. E. Choy, J. Chung, H. S. Yoo, M. H. Han, and D. Y. Shin. 1999. p53 negatively regulates cdc2 transcription via the CCAAT-binding NF-Y transcription factor. J. Biol. Chem. 274:29677–29682.
   PubMedGoogle Scholar
• Yun, J., H. D. Chae, T. S. Choi, E. H. Kim, Y. J. Bang, J. Chung, K. S. Choi, R. Mantovani, and D. Y. Shin. 2003. Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway. J. Biol. Chem. 278:36966–36972.
   PubMedGoogle Scholar
• Zacchi, P., M. Gostissa, T. Uchida, C. Salvagno, F. Avorio, S. Volinia, Z. Ronai, G. Blandino, C. Schneider, and G. Del Sal. 2002. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 419:853–857.
   PubMed Web of Science ®Google Scholar
• Zhang, X., W. Wharton, Z. Yuan, S. C. Tsai, N. Olashaw, and E. Seto. 2004. Activation of the growth differentiation factor 11 gene by the histone deacetylase (HDAC) inhibitor trichostatin A and repression by HDAC3. Mol. Cell. Biol. 24:5106–5118.
   PubMedGoogle Scholar
• Zwicker, J., F. C. Lucibello, L. A. Wolfraim, C. Gross, M. Truss, K. Engeland, and R. Muller. 1995. Cell cycle regulation of the cyclin A, Cdc25C and Cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J. 14:4514–4522.
   PubMed Web of Science ®Google Scholar